The DOI matches its Crossref record; 53 of the 56 references it cites were found in a registry or an index.
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Open accessAbstract
Tumor cells increase the use of anabolic pathways to satisfy the metabolic requirements associated with a high growth rate. Transformed cells take up and metabolize nutrients such as glucose and glutamine at high levels that support anabolic growth. Oncogenic signaling through the PI3K/Akt and Myc pathways directly control glucose and glutamine uptake, respectively. In order to achieve elevated rates of nucleotide biosynthesis, neoplastic cells must divert carbon from PI3K/Akt-induced glycolytic flux into the nonoxidative branch of the pentose phosphate pathway to generate ribose-5-phosphate. This redirection of glucose catabolism appears to be regulated by cytoplasmic tyrosine kinases. Myc-induced glutamine metabolism also increases the abundance and activity of different rate-limiting enzymes that produce the molecular precursors required for de novo nucleotide synthesis. In this review, we will focus on recent progress in understanding how glucose and glutamine metabolism is redirected by oncogenes in order to support de novo nucleotide biosynthesis during proliferation and how metabolic reprogramming can be potentially exploited in the development of new cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cytosolic glutamine supports nucleotide biosynthesis, which is essential for rapidly proliferating cells30.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Self-citationHypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc882 · Cited by 1,658
Flagged first, then by citations
3 of the 56 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–351 of 351
FM-GA and CM-GA for Gene Microarray Analysis
Liang, L. R., Palomino, R. A. B., Zhao, L., Mandal, V., & Kumar, D. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5913-3_23
Han, S. (2013) · Lu Zone Ul (Laurentian University)
Cytotoxic Drugs and their Effects on Bladder Function
Kang, S. H. (2015) · e-publications@bond (Bond University)
Targeting Could Circumvent Various Chemoresistance
Mijatovic, T., & Robert Kiss, A. (2013)
Hamzah, S. S. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33758431
He, T., Xu, C., & Zhang, X. (2019) · Springer eBooks · doi:10.1007/978-981-13-6198-2_9
Metabolic effects of oncogenic K-Ras in cancer cells
Bergner, R. (2018) · doi:10.25560/82596
Comparable metabolism in pregnancy and cancer: A universal role of the Warburg effect
Soeters, P. B., & de Leeuw, P. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820205-0.00018-9
Villarreal, B., & Nadilly, Y. (2021) · Figshare
Jung, S. Y. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000412
Sunami, Y. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_13
Anderson, R., & Li, W. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14256970.790852808
Fukuda, M., & Bao, X. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.715497908.791052865
Skotheim, J. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727689917.793545777
van Beek, H. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733047976.793552225
Peixoto, J., Janaki‐Raman, S., Schlicker, L., Schmitz, W., Walz, S., Herold‐Mende, C. C., Soares, P., Schulze, A., & Lima, J. P. (2020) · doi:10.21203/rs.3.rs-44975/v1
DNA damage, metabolism, and epigenetic regulation
Ganguly, S., Ghanem, A., & Mian, O. Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91081-1.00001-7
Genome-scale CRISPR-Cas9 screen identifies PAICS as a therapeutic target for EGFR wild-type NSCLCPreprint
Shen, H., Yufeng, L. I., Wang, J., Mao, J., Zheng, H., Zhu, L., Hu, Z., Yang, S., Zhou, T., Cao, P., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2608044/v1
MetaboliticsDB: A Database of Metabolomics Analyses
Celik, M. H., Ersen, O., Saleh, T., Dokay, A., Guven, A. E., & Cakmak, A. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3563807
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C. Z., Chari, R., Li, A., Zhang, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13126629
Additional file 3 of Scaffold-mediated switching of lymphoma metabolism in culture
Bhatt, R., Ravi, D., Evens, A. M., & Parekkadan, B. (2022) · Figshare · doi:10.6084/m9.figshare.21321439
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C. Z., Chari, R., Li, A., Zhang, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13126623
Additional file 2 of Scaffold-mediated switching of lymphoma metabolism in culture
Bhatt, R., Ravi, D., Evens, A. M., & Parekkadan, B. (2022) · Figshare · doi:10.6084/m9.figshare.21321436
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C. Z., Chari, R., Li, A., Zhang, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13126620
Additional file 1 of Scaffold-mediated switching of lymphoma metabolism in culture
Bhatt, R., Ravi, D., Evens, A. M., & Parekkadan, B. (2022) · Figshare · doi:10.6084/m9.figshare.21321433
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C. Z., Chari, R., Li, A., Zhang, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13126635
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C. Z., Chari, R., Li, A., Zhang, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13126626
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C. Z., Chari, R., Li, A., Zhang, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13126632
Cancer Nanotheranostics: Emerging Strategies for Diagnosis and Therapeutics in Cancer Metabolism
Shreya, S., Mohapatra, D., & Sahu, A. N. (2025) · Springer eBooks · doi:10.1007/978-981-95-3746-4_8
Dynamics of natural killer cell function upon recurrent stimulation
One, J., Narayan, J., Cichocki, F. M., Hu, W., & Azarin, S. M. (2026) · Biotechnology Progress · doi:10.1002/btpr.70100
Profiling the pancreatic cancer secretome with metabolic glycoengineering
Dammen‐Brower, K., Zhu, S. E., Agatemor, C., Aafreen, S., Dharharma, V., Saeui, C. T., Li, H., Song, J., Buettner, M. J., Kwagala, K. R., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111243
Zhang, S., Xu, R., Zheng, Q., Chen, B., & Li, W. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1722368
Díaz-Ruiz, R. (2010) · theses.fr (ABES) · doi:10.70675/3c8b9754z0456z4b96z82bez6ef7053f46ec
Metabolic fueling of hematopoietic stem cell differentiation to the erythroid lineage
Oburoglu, L. (2014) · theses.fr (ABES) · doi:10.70675/2a8ca582z1bd3z4b90z96c1z5964d1e426b9
Étude de la régulation de la biogénèse mitochondriale chez la levure Saccharomyces cerevisiae
Bouchez, C. L. (2020) · theses.fr (ABES) · doi:10.70675/55097e67z982dz4f15z8b14zb35f36cc3a49
Hétérogénéité métabolique des gliomes : apport de la spectroscopie RMN HRMAS
Bund, C. (2020) · theses.fr (ABES) · doi:10.70675/2f880f7az9a01z463fz9f4az0dcaad5fcf59
Nucleotide Metabolism and DNA Repair: Implications in Cancer Treatments
Priyadarshi, N., Abbas, F. E., Thakur, D., Thakur, S., & Dilawari, R. (2026) · DNA · doi:10.3390/dna6020025
Митохондрии – «Ахиллесова пята» в регенерации CD4+ T-лимфоцитов при ВИЧ-инфекции
Владимирович, Ш. К. (2026) · Perm Scientific Center Journal · doi:10.7242/2658-705x/2026.2.8
Zhang, M., Zhu, J., Zhang, H., Zhang, J., Zhao, J., Chen, Q., Zeng, Y., Li, J., Huang, J., & Liu, Z. (2026) · Oncogene · doi:10.1038/s41388-026-03917-3
Geng, Q., Zhang, L., Wang, Z., Liang, K., Cheng, F., Chen, J., Xi, Y., Jiao, X., Hou, J., Farooq, M., et al. (2026) · Animal Bioscience · doi:10.5713/ab.260260
Nuclear IDH3A Drives Transcriptional Programs in Melanoma via the YBX1–JUN/FOS Axis
Ran, J., Fang, Y., Ruan, S., Wang, J., Liu, S., Mao, Y., Hou, D., Wang, Y., Ye, Z., Li, Q., et al. (2026) · Advanced Science · doi:10.1002/advs.77762
Elbashir, R., Abbott, K. L., Ramesh, D. L., Ali, A., Shevzov-Zebrun, A., Barbeau, A. M., Wu, M., Ward, A. P., Gültekin, Y., Do, B. T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.13.750663
BindingDB (2022) · UC San Diego · doi:10.7270/q2rf5zqt
The Dual Role of HIF Hydroxylase PHD3 in Cancer Cell Survival
Rantanen, K. (2012) · UTUPub (University of Turku)
Metadata
- Authors
- Tong, X., Zhao, F., & Thompson, C. B.
- Affiliations
- Abramson Cancer Center (US)
- Corresponding author
- Tong, Xuemei
- Zhao, Fangping
- Thompson, Craig B
- Venue
- Current Opinion in Genetics & Development
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 32-37
- ISSN
- 0959-437X (ISSN-L)
- PMC
- PMC2707261
- OpenAlex
- W2002869675
- Cited by
- 351
- References
- 56
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 22 · 2023: 20 · 2022: 22 · 2021: 24 · 2020: 32 · 2019: 20 · 2018: 18 · 2017: 15 · 2016: 17 · 2015: 26 · 2014: 17 · 2013: 15 · 2012: 33
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Genetics & Development (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA092660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cancer metabolism, metabolic reprogramming, PI3K/Akt signaling, c-Myc, glucose metabolism, glutamine metabolism, pentose phosphate pathway, ribose-5-phosphate, glycolysis, oncogenic signaling, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Glucose, Glutamine, Glycolysis, Humans, Models, Biological, Neoplasms, Pentose Phosphate Pathway, Ribosemonophosphates, Proto-Oncogene Proteins c-myc, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
